Evidence map›Paper›PMID 24121261›Full record

ArticleEndocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Frax prediction without BMD for assessment of osteoporotic fracture risk.

Ramesh Keerthi Gadam, Karen Schlauch, Kenneth E Izuora

Abstract read
In one paragraph

Article in Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Article
  3. Comparative effectiveness of denosumab vs alendronate among postmenopausal women with osteoporosis.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. [Value of a nomogram model based on IDEAL-IQ for predicting early bone mass loss].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Bone health assessment in clinical practice is infrequenty performed in patients with chronic pancreatitis.Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · 2020
    Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. The Effectiveness of Osteoporosis Screening and Treatment in the Midwest.Geriatric orthopaedic surgery & rehabilitation · 2018
    Article
  20. FRAX Prediction With and Without Bone Mineral Density Testing.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ramesh Keerthi GadamDepartment of Internal Medicine, University of Nevada School of Medicine, Las Vegas, Nevada.
Karen Schlauch
Kenneth E Izuora
University of Nevada, Reno · USUniversity of Nevada, Las Vegas · US

Funding

Outreach/Diversity/Pipeline ProjectP20GM103440 · NIGMS · UNIVERSITY OF NEVADA RENO · PI Eduardo A Robleto · 2012 to 2026
$58.0M
UNDERGRADUATE RESEARCH AND TRAININGP20RR016464 · NCRR · UNIVERSITY OF NEVADA RENO · PI REIBER, CARL · 2001 to 2011
$30.3M
NCRR NIH HHS 5P20RR016464-11NCRR NIH HHS P20 RR016464NIGMS NIH HHS 8 P20 GM103440-11NIGMS NIH HHS P20 GM103440
6 · The paper itself

Abstract

objectiveTo compare Fracture Risk Assessment Tool (FRAX) calculations with and without bone mineral density (BMD) in predicting the 10-year probability of hip and major osteoporotic fractures (MOF).

methodsA cross-sectional review of patients requiring screening for osteoporosis as part of their routine medical care was conducted. Postmenopausal women and men over 50 years of age who were never diagnosed with osteoporosis or treated with U.S. Food and Drug Administration-approved agents for osteoporosis were included. Height, weight, FRAX questionnaire, femoral neck BMD, and T-score data were obtained. FRAX scores with BMD (FRAX/BMD) and without BMD (FRAX) were calculated. Subjects were separated on the basis of identical and different treatment recommendations. Fracture risk factors were compared between groups using simple Student's t test analysis of numerical variables and Fisher's exact test analysis of binary variables.

resultsOf 151 total subjects, 127 (84%) had identical fracture risk predictions with or without BMD included in the FRAX calculation. Thirty subjects met treatment criteria and 97 did not, but the FRAX prediction was the same with risk factors alone or with risk factors plus BMD. Age was the only risk factor that was significantly different between those with identical and different predictions (median age, 64.42 and 76.25 years, respectively; P<.001).

conclusionIn most cases, FRAX alone provides the same prediction as FRAX with BMD. Younger age is more indicative of an identical prediction.

Indexed as

AdultAgedAged, 80 and overBone DensityCross-Sectional StudiesFemaleHumansMaleMiddle AgedOsteoporosisOsteoporotic FracturesRisk AssessmentRisk Factors

Identifiers

PMID24121261
PMCPMC4016963
OpenAlexW2033215931

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.